Asia Fresh News

Asia Fresh Stories

Archive for September 15th, 2015

More than 96 Percent of Claimants Opt-In to ACTOS Resolution Program; Takeda Expects Resolution to Become Effective Once Submission Review Completed; Takeda Stands Behind ACTOS

leave a comment »

DEERFIELD, Ill., /PRNewswire/ — Takeda Pharmaceutical Company Limited (TSE: 4502) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (collectively “Takeda”), today announced that more than 96 percent of eligible claimants have opted into the ACTOS (pioglitazone HCl) product liability resolution program that was announced on April 28, 2015. Takeda now is evaluating the submissions to determine whether they satisfy various criteria specified under terms of the resolution program. Takeda expects the resolution program to become effective upon completion of that review.

Per the resolution program, a 95 percent participation or greater triggers a $2.37 billion payment by Takeda into a settlement fund. However, that figure will rise to $2.4 billion if after a review of the claims submissions it is determined that 97 percent or more of them meet the settlement criteria. The settlement would not affect Takeda’s ability to pay dividends.

Once the settlement is operative, the company also will have resolved seven of the nine previously tried ACTOS product liability cases, which have been in various stages of the appeals process.  In Cooper v. Takeda, which was tried in Los Angeles, California, Takeda is appealing from a judgment against the company. In Triana and Cipriano v. Takeda, the plaintiffs are challenging through post-trial motions a judgment in favor of Takeda.

Takeda’s decision to pursue this settlement does not change the company’s continued commitment to ACTOS. ACTOS continues to be available as a treatment option in the U.S. and other countries. In fact, pioglitazone has been approved for use in 95 countries, including the U.S., Japan, several in Europe, Australia, Brazil, Canada andRussia, to highlight a few.

Takeda believes the company acted responsibly with regard to ACTOS, and firmly stands behind the substantial data confirming a positive benefit/risk profile for ACTOS. The data sets include a 10-year, prospective cohort study, conducted by the University of Pennsylvania and Division of Research at Kaiser Permanente Northern California, which showed no statistically significant increased risk of bladder cancer among patients ever exposed to pioglitazone, and the Pan European Multi-Database Bladder Cancer Risk Characterization Study, a large multi-database retrospective matched cohort study.

The settlement would reduce the uncertainties of complex litigation for the company and resolve a high percentage of the ACTOS product liability claims. The settlement would allow the company to fully focus on its mission of creating better health outcomes for people worldwide through innovation.

Indication for ACTOS
ACTOS (pioglitazone) is a prescription medicine used with diet and exercise to improve blood sugar (glucose) control in adults with type 2 diabetes. ACTOS is not for the treatment of type 1 “juvenile” diabetes or diabetic ketoacidosis (increased ketones in blood or urine).

Important Safety Information

ACTOS can cause or worsen heart failure. ACTOS can cause the body to keep extra fluid (fluid retention), which leads to swelling (edema) and weight gain. Extra body fluid can make some heart problems worse or lead to heart failure. Heart failure means the heart does not pump blood well enough. Patients should not take ACTOS if they have severe heart failure. If patients have heart failure with symptoms such as shortness of breath or swelling, even if these symptoms are not severe, ACTOS may not be right for them. Patients should call their doctor right away if they experience swelling or fluid retention (especially in the ankles or legs), shortness of breath or trouble breathing (especially when lying down), an unusually fast increase in weight, or unusual tiredness.

ACTOS may not be right for everyone. Serious side effects may happen to people taking ACTOS.

Patients should not take ACTOS if they are allergic to any of its ingredients.

ACTOS may cause liver problems. Patients should call their doctor right away if they experience nausea, vomiting, stomach pain, unusual or unexplained tiredness, loss of appetite, dark urine, or yellowing of the skin or eyes, as these could be symptoms of liver damage.

Women are at higher risk of having broken bones (fractures) while taking ACTOS.

There may be an increased chance of having bladder cancer when patients take ACTOS. Patients should not take ACTOS if they are receiving treatment for bladder cancer. Patients should tell their doctor right away if they have blood or a red color in the urine, have an increased need to urinate, or have pain while they urinate, as these may be symptoms of bladder cancer.

When taking ACTOS with insulin or other anti-diabetic medications (especially sulfonylureas), hypoglycemia (low blood sugar) may occur. Lightheadedness, shakiness, dizziness, or hunger may mean that a patient’s blood sugar is too low. Patients should talk to their doctor if low blood sugar is a problem for them.

Some patients have experienced visual changes while taking ACTOS. If patients experience vision problems, patients should consult their doctor immediately. Patients should have their eyes checked regularly.

If a woman is of childbearing age, but does not have monthly periods, she should talk to her doctor before taking ACTOS, as it could increase her chance of becoming pregnant.

It is not known if ACTOS can harm an unborn or nursing baby. Patients should talk to their doctor if they are pregnant, planning to become pregnant, breastfeeding, or planning to breastfeed.

Adverse Reactions
The most common side effects (>5%) of ACTOS include cold-like symptoms, headache, sinus infection, muscle pain, and sore throat.

Drug Interactions
Patients should tell their doctor about all the medicines, vitamins, and supplements they take. ACTOS and some other medicines can affect each other. Patients may need to have their dose of ACTOS or certain other medicines changed.

Patients are encouraged to report negative side effects of prescription drugs to the FDA. or call 1-800-FDA-1088.

Please see the accompanying Complete Prescribing Information and Medication Guide for ACTOS.

About Takeda Pharmaceuticals U.S.A., Inc.
Based in Deerfield, Ill., Takeda Pharmaceuticals U.S.A., Inc. is a subsidiary of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. TPUSA markets oral diabetes, CNS, rheumatology and gastroenterology treatments. Its pipeline includes compounds for metabolic and cardiovascular disease, gastroenterology, neurology and other conditions. To learn more, visit

This press release contains forward-looking statements. Forward-looking statements include statements regarding Takeda’s plans, outlook, strategies, results for the future, and other statements that are not descriptions of historical facts. Forward-looking statements may be identified by the use of forward-looking words such as “may,” “believe,” “will,” “expect,” “project,” “estimate,” “should,” “anticipate,” “plan,” “assume,” “continue,” “seek,” “pro forma,” “potential,” “target,” “forecast,” “guidance,” “outlook” or “intend” or other similar words or expressions of the negative thereof. Forward-looking statements are based on estimates and assumptions made by management that are believed to be reasonable, though they are inherently uncertain and difficult to predict. Investors are cautioned not to unduly rely on such forward-looking statements.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. Some of these risks and uncertainties include, but are not limited to, (1) the economic circumstances surrounding Takeda’s business, including general economic conditions in Japan, the United States and worldwide; (2) competitive pressures and developments; (3) applicable laws and regulations; (4) the success or failure of product development programs; (5) actions of regulatory authorities and the timing thereof; (6) changes in exchange rates; (7) claims or concerns regarding the safety or efficacy of marketed products or product candidates in development; and (8) integration activities with acquired companies.

The forward-looking statements contained in this press release speak only as of the date of this press release, and Takeda undertakes no obligation to revise or update any forward-looking statements to reflect new information, future events or circumstances after the date of the forward-looking statement. If Takeda does update or correct one or more of these statements, investors and others should not conclude that Takeda will make additional updates or corrections.

Written by asiafreshnews

September 15, 2015 at 4:17 pm

Posted in Uncategorized

CellPoint Mobile Offers Travel Bank mWallet(TM) Solution for Airlines

leave a comment »

-Fully branded, plug-and-play mobile wallet bypasses high cost & data integration hurdles, enabling deployment in a matter of weeks

BARCELONA, Spain /PRNewswire/ — CellPoint Mobile, a global payment solutions company whose technology enables airlines to easily manage and control the complex and costly travel payments ecosystem, is rolling out a passenger-centric, off-the-shelf mobile wallet solution for airlines whose passengers are increasingly managing their travel-related purchases, transactions and records from smartphones and mobile devices.

The Travel Bank mWallet™ solution enables airlines to boost revenues and income streams through an airline-branded, omni-channel universe offering numerous paths to purchase, reduced customer acquisition costs, and higher conversion on ticket sales and ancillary revenue opportunities for millions of passengers. According to Air Transport World and SITA, 97% of 2014 airline passengers traveled with a smartphone, laptop or tablet, and 18% carried all three.

Within a centrally controlled environment, CellPoint Mobile’s Travel Bank mWallet™ supports Electronic Miscellaneous Documents (EMD), loyalty rewards, coupons and payment methods as tender, allows airlines to convert Denied Board Compensation (DBC) events and other types of compensation into revenue opportunities, and can integrate seamlessly with other electronic payment wallets, such as Apple Pay, Google Pay and MasterPass.

The ewallet also serves as a mobile repository of passenger travel documents, including boarding passes, tickets, loyalty program currencies and rewards status as well as notifications and other travel and payment data. Operating in online and offline mode, the Travel Bank mWallet™ ensures continuous access to passenger records.

Airline-branded mobile solution
“Today’s airlines recognize the importance of facilitating and aiding passenger’s journeys in the mobile environment, but carriers are often challenged by costs, time and data integration hurdles of rolling out an airline-branded mobile wallet, as well as the added costs of attracting and acquiring customers into their online universe,” said Kristian Gjerding, CEO of CellPoint Mobile.

“With this plug-and-play solution, airlines can deploy a fully branded digital universe across all channels in a matter of weeks, not months,” he says. “They can manage tender and non-tender records, enjoy higher conversion on both ticket sales and ancillary products/services, and boost revenues by leveraging additional cross-selling opportunities that emerge when passengers stay within an airline’s branded universe for purchases and payments.”

Gjerding and members of the CellPoint team will attend the IATA World Financial Symposium (WFS) Sept. 16-17 inBarcelona, where Gjerding will discuss “Cyber Attack! Beyond Firewalls” on Sept. 16 during a panel presentation on payments and loyalty program fraud. CellPoint Mobile is a 2015 WFS Silver Sponsor of the WFS. On Sept. 2, CPM also announced a solution that enables airlines to roll out Apple Pay in a matter of hours or days, rather than weeks or months.

For more information about CellPoint Mobile, the Travel Bank mWallet™ solution, or to schedule an interview withKristian Gjerding, please contact Vanessa Horwell at or +44.203.372.4809 in the UK, orKarina Castano at +1.305.749.5342 x240 in the US.

About CellPoint Mobile: Making Travel Payments Easier
CellPoint Mobile helps airlines around the world navigate and own the complex payments ecosystem from beginning to end, regardless of their passengers’ preferred currency, payment method, device or channel.  Its technology infrastructure, solutions and professional services enable airlines to manage and process payments and transactions from a single, data-integrated platform, regardless of channel, device or currencies. With offices inLondon, Miami, Copenhagen and Pune, CellPoint Mobile serves global and regional airlines. Since 2007, its Commerce Orchestration Platform has helped companies across the world fulfill their digital strategy, increase sales and improve margins.

Source: CellPoint Mobile

Written by asiafreshnews

September 15, 2015 at 4:06 pm

Posted in Uncategorized

ICON and IBM to Revolutionise Clinical Trial Feasibility, Patient Recruitment and Study Start-up Timelines

leave a comment »

-ICON applies IBM Watson Clinical Trial Matching to Oncology Clinical Trials

DUBLIN /PRNewswire/ — ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it is working with IBM (NYSE: IBM) to help reduce the time and costs of drug development, while also offering patients enhanced quality of care by connecting them to relevant clinical trials. ICON will tap Watson’s cognitive computing power to help automate the cumbersome process of identifying patients who meet the criteria for a clinical trial, and to analyse protocols to assess trial feasibility and identify optimal trial sites.

Initially, ICON is applying Watson Clinical Trial Matching to its breast, lung, colon and rectal cancer trials. The solution enables ICON to advise sponsors how many patients match their trial criteria, where they are located and how they will recruit them. IBM’s Watson Health Cloud will facilitate access to de-identified patient data, including 50 million patient records contained in the data set from Explorys, which IBM acquired in April. At the same time, ICON enhances IBM Watson’s capabilities by providing expertise into clinical trial protocols and clinical operations.

The cost and time involved in clinical trials is considerable. More than $1.3B is spent on patient recruitment by drug developers each year and yet fewer than 5% of cancer patients participate in a clinical trial. It also typically takes 6-12 months to start up a global phase III drug trial and another 12 months to enroll the required number of patients.

Commenting on the announcement, ICON’s Chief Operating Officer, Dr. Steve Cutler, said: “Recruiting the required number of patients for clinical trials is a constant challenge for our customers and can represent more than 30% of total study costs. By applying IBM Watson to our clinical trials, we have the potential to revolutionise clinical trial feasibility, patient recruitment and study start-up timelines which will help our customers take significant time and cost from their development programmes. Together with IBM, we are also providing a better and faster way to connect patients with clinical trials that are most relevant to them. Today’s announcement is an excellent example of disruptive innovation and represents ICON and IBM’s shared vision for using industry-leading technologies and real-word data sets to improve clinical development.”

“Clinical trials are crucial in the drug and treatment development process, but when it comes to identifying appropriate trial candidates, there are significant data challenges, which can contribute to delays for bringing new therapies to market,” said Sean Hogan, Vice President and General Manager, IBM Healthcare. “Through cognitive computing and cloud-based data, our goal is to help our clients accelerate the time it takes to complete clinical trials and reach conclusive trial results.”

About IBM Watson: Pioneering a New Era of Computing

Watson is the first commercially available cognitive computing capability representing a new era in computing. The system, delivered through the cloud, analyzes high volumes of data, understands complex questions posed in natural language, and proposes evidence-based answers. Watson continuously learns, gaining in value and knowledge over time, from previous interactions. In April 2015, the company launched IBM Watson Health and the Watson Health Cloud platform. The new unit will help improve the ability of doctors, researchers and insurers to innovate by surfacing new insights from the massive amount of personal health data being created daily. The Watson Health Cloud allows this information to be de-identified, shared and combined with a dynamic and constantly growing aggregated view of clinical, research and social health data.

About ICON plc

ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. With headquarters in Dublin, Ireland, ICON currently, operates from 81 locations in 37 countries and has approximately 11,300 employees.

Further information is available at

Follow ICON on Twitter, LinkedIn and Facebook to receive the latest company updates.

Learn more about this story at

This press release contains forward-looking statements. These statements are based on management’s current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word “expected” and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are available on the SEC’s website at

Source: ICON Clinical Research Hong Kong Limited

Related stocks: NASDAQ-NMS:ICLR

Written by asiafreshnews

September 15, 2015 at 3:47 pm

Posted in Uncategorized

Digital Media Asia 2015 Conference to Take Place in HK

leave a comment »

SINGAPORE /PRNewswire/ — The World’s Association of newspapers and news publishers (WAN-IFRA) leading Asian digital event – Digital Media Asia (DMA) – will take place this year in Hong Kong on 17-19 November. Since its launch in 2009,  DMA has grown to become the largest new media conference dedicated to the publishing industry in Asia.

The event offers three focussed days of conference and masterclasses and a foyer expo. The winners of the 6th Asian Digital Media Awards, organised by WAN-IFRA and Google, will also be presented during the conference.

Media experts and executives from Asia and all over the world will discuss at DMA2015 the issues that are currently reshaping the online news media business.

Speakers from leading media organisations such as The Guardian, Bloomberg, Google or the Wall Street Journal will share case studies and best practices on the following topics:

Media for Millennials

Attract and build a business around a younger demographic. Millennials, aged roughly between 15 and 32 years old, are always-on, digital natives and video consumers. How to answer their specific content consumption patterns? What lessons can we learn from Buzzfeed, Vox, Vice and other successful digital pure-players?

Programmactic & Native Advertising

Develop efficient ad strategies for a mobile-first media environment. Keep premium pricing and stay safe from market fraud.

Data Strategy

Let’s make data actionable. Explore data enabled diversification strategies such as e-commerce and e-Marketing. Deal adequately with data privacy issues.

Audience Intelligence

Create, understand and monetise your audience. Increase referral from social media platforms and turn social readers into subscribers.

Top 5 digital priorities

Check you’re on track for 2015. Leading media executives present their digital strategies and tell you where they plan to focus their efforts in the coming months. Benchmark your own efforts with peers of the industry.

Content optimisation

What triggers customers to pay for digital content? Marketing digital content outside of the traditional media platforms and to new audiences is key to success in today´s media landscape.

Cultivating a culture of innovation

Inject new decision-making processes and workflows. Get inspiration from brilliant start-ups and innovative pure players.

Web TV – Video

Strategies to create (ad friendly) quality content. Reach a critical size. How to choose the right distribution platform? What are the real monetisation opportunities?

In addition to the conference sessions, vendors of business solutions, services and equipments will highlight their latest offerings at the Digital Media Asia Expo. Catch up with the latest tools for optimizing your editorial and advertising operations and boosting your digital business.

Event Venue & Hotel

The Mira Hotel, located at 118 Nathan Road, Tsim Sha Tsui, Hong Kong, is the official event venue and hotel for DMA 2015. It is centrally located in the heart of Hong Kong’s commercial, shopping, dining and entertainment district and a close walk to the local MTR.

For more information on The Mira Hotel and booking link, please visit our website


On November 17, DMA will offer in-depth sessions on mobile video and online classifieds leaded by recognised international experts with a notorious understanding of the Asian markets’ specificity and challenges. DMA will also host an exceptional half day workshop organised by The Guardian News & Media Publisher Network, which will offer unique insights on how The Guardian is tackling partnerships with digital pure-players and technology suppliers, such as Facebook, Google, Samsung or Apple.

Confirmed speakers include so far:
Anjali Kapoor, Head of Digital, Asia Pacific, Bloomberg, HK
Suzy Hay, Global Director, Content Partnerships, The Guardian, UK
Yumiko Ono, Asia Audience Engagement Editor, Wall Street Journal, HK
John Pullman, Global Editor of Video and Pictures, Reuters, UK
Peter Zollman, CEO, AIM, USA
Jeremy Butteriss, MD, Partner Business Solutions – APAC, Google, Singapore
Ben Shaw, Director of Global Advisory, WAN-IFRA, Germany
Peter Lamb, President  Lamb Consulting, USA

For more information on registration, please contact Wilson Leong at +65-6562-8446 or

For more information on Sponsorship/ Exhibition, please contact Nurul Fitriyana at +65-6562-8444

Hashtag: #DMAHK15

Logo –

Source: WAN-IFRA
Related Links:

Written by asiafreshnews

September 15, 2015 at 3:43 pm

Posted in Uncategorized

2015 Change Management Institute Conference: Change in the Age of Disruption

leave a comment »

-11-12 November Sydney, London & Globally online

SYDNEY /PRNewswire/ — The Change Management Institute (CMI) 2015 Conference will investigate emerging trends in organisational change. The conference has assembled a program of international thought leaders in change to explore new concepts and challenge conventional thinking in a shared learning forum – spanning the globe.

The CMI conference will be staged live in London and Sydney on the 11-12 November and will be streamed live and available for download to delegates, including for the first time online delegates from around the world. Early Bird registration is now open and delegates can purchase online tickets for as little as USD90 or GBP60.

The CMI conference speakers represent some of the profession’s new wave of change management thinking and include Britain’s ‘Management Lab’s’ Michele Zanini, NHS’s Chief Transformation Office Helen Bevan along with best-selling authors and change provocateurs like Dr. Jason Fox and USA based Stowe Boyd.

Change Management President, Caroline Perkins explains, This is a conference with a very big twist. This is not a ‘sit back and listen’ event. This is an event where you can be involved with developing and publishing new thinking in change and How Change is Changing‘.”  Think TEDx, think Pecha Kucha, think World Cafe.

The Change Management Institute conference is a truly global event where delegates will be able to attend and actively participate either in person or from anywhere in the world online.  All the presentations (over 20 hours of video content) will be available to stream and download and represents great value to anyone professional manager and leader facing the challenges in the ‘Age of Disruption’.

Media contact: +61-4-0955-0364 or

Conference website:
Conference email:
Twitter: @ChangeMgtIns #cmidisrupt

The Change Management Institute (CMI) is a global, independent, not-for-profit organisation set up to promote and develop the profession of change management internationally. To learn more, visit the Change Management Institute website:

Source: Change Management Institute

Written by asiafreshnews

September 15, 2015 at 3:40 pm

Posted in Uncategorized

DHL Global Forwarding Appoints Charles Kaufmann as Chief Executive Officer for North Asia

leave a comment »

-Charles Kaufmann heads up Mongolia, North Korea, South Korea and Taiwan in addition to Value Added Services for Asia Pacific

SINGAPORE /PRNewswire/ — DHL Global Forwarding, leading provider of air, sea and road freight services in Europe and Asia, has appointed Charles Kaufmann as Chief Executive Officer for North Asia and he will continue to head Value Added Services for Asia Pacific with this appointment effective from 1 August 2015. In his new role, Charles will be responsible for North Asia market operations which cover Mongolia, North Korea, South Korea and Taiwan. He will continue to report directly to Kelvin Leung, CEO, DHL Global Forwarding Asia Pacific.

Charles Kaufmann, CEO, DHL Global Forwarding North Asia & Head, Value Added Services, DHL Global Forwarding Asia Pacific
Charles Kaufmann, CEO, DHL Global Forwarding North Asia & Head, Value Added Services, DHL Global Forwarding Asia Pacific

According to Kelvin Leung, CEO, DHL Global Forwarding Asia Pacific, “North Asia’s exports have become a major engine of growth for the global economy: exports from both South Korea and Taiwan have hit all-time highs in 2014[1], driven by key industries like consumer electronics and automobiles that demand safe, timely and industry-unique logistics solutions to stay competitive. For emerging markets like Mongolia, where foreign investments have hit consistent highs of US$16 billion (Euro 14 billion) per quarter since mid-2014[2], core export industries – like mining, which accounts for nearly 90 percent of all export revenues in 2014[3] – will require scalable and high-volume logistics networks to reach their full potential.”

“Covering a range of economies from primary industry producers to highly sophisticated technology and services markets, North Asia demands highly nuanced approaches to trade and logistics. Charles is an experienced leader with a proven track record representing DHL in North Asia. With his in-depth knowledge of the region, we are confident that he will be able to lead the next wave of growth for us,” Kelvin added.

“Freight is a thriving business in North Asia and DHL Global Forwarding is very committed to the development of this sector in countries we operate in. North Asia has enormous growth potential and we will see business flourish in the years to come. I am very excited to pave the way for DHL to reach higher peaks and lead a passionate team that is devoted to expanding our operations in the North Asia global forwarding industry,” said Charles.

Having spent more than 40 years in the logistics industry, Charles has rich experience conducting business in North Asia and is very familiar with the industry landscape in the region. He was appointed CEO for Japan and Korea in 2006, before becoming the Chief Operating Officer for North Asia Pacific in 2011. He managed air freight operations, implemented cost-efficient purchasing and pricing policies to achieve strong year-on-year revenue growth and set new standards of operational excellence across the 21 countries he was responsible for. In 2012, Charles became Head of Air Freight and Value Added Services in DHL Global Forwarding Asia Pacific where he strengthened freight forwarding activities and the multimodal network in the region.

Most recently, Charles held the role of Senior Vice President, Operations and Value Added Services for Asia Pacific. He was driving the operations of all DHL Global Forwarding products in Asia Pacific with a strong focus on cost optimization. He will continue to develop Value Added Services as part of this new role. He currently sits on the Asia Pacific Management Board for DHL Global Forwarding.

Note to Editors:

DHL Global Forwarding Value Added Services cover customized road transport network services under Road Freight; Multimodal Solutions which offer the most efficient combination of multiple transport modes with optimized lead times; value added services to air and ocean freight shipments through Integrated Warehousing Services; International Supply Chain Management across different transport modes and international borders; a carrier-neutralLead Logistics Partner service which offers end-to-end supply chain management; Customs brokerage services to ensure uniform, consistent and compliant trade activities; Control Tower services for freight operations and supply chain visibility; and Security which offers freight security management, business continuity management and state-of-the-art risk assessment.

– End –

On the Internet:

Follow us at:

DHL – The logistics company for the world

DHL is the leading global brand in the logistics industry. DHL’s family of divisions offer an unrivalled portfolio of logistics services ranging from national and international parcel delivery, international express, road, air and ocean transport to industrial supply chain management. With more than 325,000 employees in over 220 countries and territories worldwide, they connect people and businesses securely and reliably, enabling global trade flows. With specialized solutions for growth markets and industries including e-commerce, technology, life sciences and healthcare, energy, automotive and retail, a proven commitment to corporate responsibility and an unrivalled presence in developing markets, DHL is decisively positioned as “The logistics company for the world”.

DHL is part of Deutsche Post DHL Group. The Group generated revenues of more than 56 billion euros in 2014.

[1] South Korea’s exports hit a high of US$51.6 billion in October 2014 while Taiwan’s hit a high of TWD842 billion in August 2014. See and


[3] (p2)

Photo –

Logo –

Source: DHL

Written by asiafreshnews

September 15, 2015 at 3:37 pm

Posted in Uncategorized

CNBC Announces 14th Asia Business Leaders Awards Nominees

leave a comment »

-UNIQLO Founder Tadashi Yanai named Lifetime Achievement Award winner

SINGAPORE /PRNewswire/ — CNBC, First in Business Worldwide, today announced the shortlisted candidates and Lifetime Achievement Award recipient for the upcoming 14th Asia Business Leaders Award (ABLA) which will be held on Thursday, 29 October 2015 in Bangkok, Thailand. In addition to the Lifetime Achievement Award, a total of 45 business leaders from 10 countries will vie for the remaining five awards.

This year, Chairman, President and CEO of Fast Retailing Co., Ltd, Mr Tadashi Yanai will be awarded the ABLA Lifetime Achievement Award for his significant contributions over the course of his 44-year career. Mr Yanai has shaped and developed the economic landscape in Japan and around the world through Fast Retailing Co., Ltd, a public Japanese retail holding company for notable brands like UNIQLO, Theory, Helmut Lang, Comptoir des Cotonniers and more.

“We are delighted that Mr Tadashi Yanai has accepted this year’s CNBC Lifetime Achievement Award. His entrepreneurial spirit, contribution to retail and commitment to corporate citizenship is unparalleled,” said Mr KC Sullivan, President and Managing Director, CNBC International.

“It is an honor to be awarded a Lifetime Achievement Award by prestigious business channel CNBC. I could not have been selected for the award without the contributions of Fast Retailing employees worldwide, and I wish to express my thanks to them,” said Mr Tadashi Yanai.

The five remaining award categories are the Asia Business Leader of the Year Award, Asia Innovator of the Year Award, Asia Talent Management Award, Corporate Social Responsibility Award and Thailand Business Leader Award.

India leads the pool of 45 shortlisted candidates with nine individuals in the running, followed by Japan (seven candidates), Thailand (six candidates), Singapore and Indonesia (five candidates each), Malaysia (four candidates),the Philippines (three candidates), Hong Kong and Korea (two candidates each) and mainland China and Taiwan(one candidate each). The five winners will be unveiled on Thursday, 29 October 2015.

For the list of shortlisted ABLA candidates, please visit

Contact Information:

Mike Cheong

Communications Manager, CNBC Asia Pacific
D: +65 6326 1123
M: +65 9852 8630

About CNBC Asia Business Leaders Awards

CNBC pioneered the Asia Business Leaders Awards (ABLA) in 2001 to salute remarkable business leaders for their continuing commitment to excellence, developing best practices and innovative strategies. CNBC is proud to continue the tradition established by the Awards that define and celebrate vision, the spirit of achievement and excellence in business leadership in Asia.

The ABLA distinguishes and honors leaders who have contributed and shaped the Asian economy, and are visionaries behind today’s outstanding businesses.

Winners of the Awards exemplify the best in leadership. They epitomize the core values of a successful leader – strength, innovation, ingenuity, knowledge and foresight – values that are imperative to carving out powerful businesses in the global economy.

For more information on ABLA, please visit

About CNBC

CNBC is the leading global broadcaster of live business and financial news and information, reporting directly from the major financial markets around the globe with three regional networks including CNBC in Asia, CNBC in EMEA and CNBC in the US. is the preeminent financial news source on the web, featuring an unprecedented amount of video, real-time market analysis, web-exclusive live video and analytical financial tools. CNBC is dedicated to CEOs, senior corporate executives; the financial services industry and private investors. The channel is available in 386 million homes worldwide. CNBC is a division of NBCUniversal.

For more information on CNBC, please visit

Source: CNBC

Written by asiafreshnews

September 15, 2015 at 3:32 pm

Posted in Uncategorized

Exegy Adds Fixed Income Data with BrokerTec Feed Handler

leave a comment »

ST. LOUIS /PRNewswire/ — Exegy Inc., a leading provider of managed services and technology for market data normalization and distribution, has announced today the availability of a feed handler for the BrokerTec ITCH electronic fixed income feed that provides real-time pricing for U.S. and Canadian treasury bonds and notes. The feed handler is available for Exegy’s lineup of hardware-accelerated appliances and embedded software ticker plant products. BrokerTec is the most recent addition to their portfolio of over 200 feed handlers for direct and consolidated feeds for global equities, commodities, derivatives, currencies, and fixed income markets.

“Our entrance into electronic fixed income market data is just another indicator of the tectonic shifts underway in the marketplace,” says chief executive officer James O’Donnell. “The center of gravity for treasury debt trading is shifting from traditional dealers to electronic market makers who represent a core constituency of our customer base. We are responding to the needs of existing customers and we expect to win new business as our abilities to service the needs of electronic fixed income traders expand,” adds O’Donnell. The BrokerTec feed handler is already in production usage on Exegy Ticker Plant and Market Data System hardware-accelerated appliances.

The release of the BrokerTec ITCH feed handler is the first major milestone in Exegy’s roadmap for supporting electronic fixed income markets. “We plan to respond to emerging opportunities in the electronic fixed income markets in much the same way that we have in the electronic currency markets, where we now support over thirty different ECNs and banks,” says chief technology officer David Taylor. When developing interfaces for additional market data feeds, Exegy places a premium on consistency and ease of use. “Our careful stewardship of our normalized data model allows our customers to easily apply existing market making and trading applications to new markets and new asset classes. This consistency and portability, combined with our performance and managed services, have made our offerings very attractive for large enterprises engaged in multi-asset trading,” adds Taylor.

About Exegy, Inc.
Exegy provides best-of-breed technology and managed services for the normalization and distribution of real-time market data to a diverse set of élite firms in the financial services industry. Today Exegy serves as a strategic partner to leading exchanges, market makers, sell-side banks, buy-side asset managers, and proprietary traders. At the heart of Exegy’s product line are purpose-built, hardware-accelerated appliances derived from an extensive portfolio of patented and patent-pending technology. For more information, please visit and follow Exegy on LinkedIn and Twitter @ExegyMarketData.

Logo –

Source: Exegy, Inc.

Related Links:

Written by asiafreshnews

September 15, 2015 at 3:20 pm

Posted in Uncategorized

Breakthrough Prize And Khan Academy Announce Breakthrough Junior Challenge For Students

leave a comment »

-$400,000 in educational prizes to be awarded for a video bringing scientific and mathematical ideas to life
-Video submissions accepted through October 7, 2015

SAN FRANCISCO /PRNewswire/ — The Breakthrough Prize and Khan Academy are joining forces to launch the Breakthrough Junior Challenge, an annual, global competition for science and math students to inspire creative thinking about fundamental concepts in the life sciences, physics or mathematics.

“This project is about unleashing young people’s capacity for fresh thinking and inspiring a new generation of scientists. We want to encourage students from around the world to share complex ideas with their peers,” said Breakthrough Prize co-founder Dr. Priscilla Chan.

Students ages 13-to-18 from countries across the globe are invited to create original videos (up to 10 minutes in length) that bring to life a concept or theory in the life sciences, physics or mathematics. The submissions will be judged on the student’s ability to communicate complex scientific ideas in the most engaging, illuminating, and imaginative ways. The deadline for submissions is October 7, 2015.

Students must register to participate at

One winner will be recognized and will be awarded a $250,000 scholarship. The teacher who inspired the winning student will win $50,000. The winner’s school can also receive a state-of-the art science lab valued at $100,000.

The Breakthrough Junior Challenge winner will also be invited to the Breakthrough Prize awards ceremony in Silicon Valley, where he or she will get to meet with giants of science, technology, media and the arts. The winning student and his or her teacher will be announced and the winning film will be presented during the live, nationally televised show, broadcast in the US by National Geographic Channel on Sunday, November 8 at 7.00pm PT, 10.00pm ET, and rebroadcast globally via National Geographic and the Fox Cable Networks.

“Breakthroughs in science and math often start with a new way of seeing things. The goal of this prize is to inspire young people to explain big ideas in math and science in new and novel ways, possibly opening all of our minds to the mysteries of the universe and leading to the breakthroughs of the future!” said Khan Academy founder Salman Khan.

In addition to creating and producing their own video entries, students will have the opportunity to participate in the peer-to-peer scoring of fellow students’ submissions. The short-listed video submissions will be reviewed by Breakthrough Prize laureates and other leaders in science, technology, and education from Khan Academy.

“I love the way that the Breakthrough Junior Challenge gives young people worldwide a creative, scientific mission, asking them to share their understanding, research and vision with others. Who better to explain and illuminate difficult ideas and concepts to young people than their peers? I’m very honored to join the judging panel,” saidBreakthrough Junior Challenge judge, author and educator Lucy Hawking.

Breakthrough Junior Challenge is funded by Mark Zuckerberg and Priscilla Chan, and Yuri and Julia Milner, through the Breakthrough Prize Foundation, based on a grant from Mark Zuckerberg’s fund at the Silicon Valley Community Foundation and a grant from Milner Global Foundation.

Breakthrough Junior Challenge is a global initiative to develop and demonstrate young people’s knowledge of science and scientific principles; generate excitement in these fields; support STEM career choices; and engage the imagination and interest of the public-at-large in key concepts of fundamental science.

The Breakthrough Prize
Founded in 2012 by Sergey Brin and Anne Wojcicki, Jack Ma and Cathy Zhang, Yuri and Julia Milner, Mark Zuckerberg and Priscilla Chan, the Breakthrough Prize is an annual award honoring outstanding achievements in life sciences, physics and mathematics. The prize aims to celebrate scientists and generate excitement about the pursuit of science as a career. Laureates of each prize are chosen by the respective Selection Committee comprised of previous recipients of the prize. In November 2014, two of its founders, Yuri Milner and Mark Zuckerberg, announced the New Horizons in Mathematics Prize for up-and-coming mathematicians, to run alongside the existing New Horizons in Physics Prize.

For more information on the Breakthrough Prizes:

Khan Academy
Khan Academy is a 501(c)3 nonprofit with a mission to change education for the better by providing a free, world-class education for anyone, anywhere. We believe that students of all ages should have free, unlimited access to the best educational content, and that they should be able to consume and master this content at their own pace. In addition, we believe that there are incredible opportunities to use intelligent software development, deep data analytics, and intuitive user interfaces to more effectively surface and present these educational resources to students and teachers around the world. Our library of content covers kindergarten to early college math, science topics such as biology, chemistry, and physics, and reaches into humanities with tutorials on economics, finance, music, philosophy, and art history. We have over 26 million registered students and to date, we have delivered over 580 million lessons and 3.8 billion exercise problems.

For further information, visit

The Breakthrough Prize Lab for the winning student’s school is designed by and in partnership with Cold Spring Harbor Laboratory (CSHL). CSHL has shaped contemporary biomedical research and education and is home to more than 600 researchers and technicians. The Laboratory’s education arm also includes an academic publishing house, a graduate school and programs for middle and high school students and teachers.

The Breakthrough Junior Challenge has also partnered with Facebook, Google Science and Google Education, and National Geographic to help reach science and math enthusiasts, educators, and students around the globe. TheNational Geographic Channels US are a joint venture between National Geographic and Fox Cable Networks. The Channels contribute to the National Geographic Society’s commitment to exploration, conservation and education with smart, innovative programming and profits that directly support its mission.

For more information, including competition rules, video submission guidelines and queries,

Please register and direct all queries on the forum page at

Source: Breakthrough Prize

Written by asiafreshnews

September 15, 2015 at 2:53 pm

Posted in Uncategorized

ICBC Credit Suisse Appoints Elvin Yu as Head of International Sales and Client Relationships

leave a comment »

HONG KONG/PRNewswire/ — ICBC Credit Suisse Asset Management International, the international arm of one of China’s largest asset managers with more than RMB754 Billion in assets under management, today announced that it has named Elvin Yu, as Head of International Sales and Client Relationships. In this role, Elvin reports to Richard Tang, the Chief Executive Officer, and will oversee all sales, marketing and client relationship functions outside China.

“International business is a top priority for us,” said Richard. “The hiring of a highly regarded and seasoned business leader in Elvin is proof of our commitment. We are very pleased to have someone of his calibre to lead the team.”

“I am delighted to join the firm and drive the international expansion at this significant point of RMB internationalization. ICBCCS is one of the world’s largest asset managers dedicated to China solutions, and has an excellent array of capabilities that offer tremendous opportunities for international clients,” said Elvin.

Elvin has more than 16 years of experience in the asset management industry. Prior to joining ICBCCS, he was the Responsible Officer, Managing Director and Head of Institutional Business for Greater China and SE Asia at Allianz Global Investors. Elvin has also held senior roles at Baring Asset Management and AXA Rosenberg, and was responsible for institutional business development in the Asia region.

The firm has also made a number of key strategic personnel appointments recently. Ricky Chau joined in July 2015as Director of Global Investment Solutions. Ricky brings more than 15 years of industry experience and was the Director of Asset Allocation at Manulife Asset Management Asia, where he managed multi-asset portfolios for retail, pension and other institutional clients.

Elaine Yu joined as Head of Legal and Compliance and is responsible for all legal, compliance and regulatory affairs for the firm. Elaine brings more than 10 years of industry experience, and before that was a solicitor with the international law firm Paul Hastings.

“ICBCCS has been dedicated to investment management in China for more than 10 years, with strong focus on our fiduciary duties and prudent investment culture,” Richard said. “We are excited to leverage on our stable teams and successful track records in China, to provide the international audience the best in class RMB solutions appropriate for their needs.”

About ICBC Credit Suisse Asset Management

ICBC Credit Suisse Asset Management Company Limited (ICBCCS) is the joint venture between the Industrial and Commercial Bank of China (ICBC) and Credit Suisse, and the investment specialist dedicated to providing Chinaand RMB asset management solutions within the ICBC Group. Since establishment in 2005, the firm has upheld the philosophy of “Value Creation through Prudent Investing”. As of Jun 30, 2015, the firm has approximately 400 employees and RMB754 billion assets under management, providing first-class investment management and advisory services for over 9 million institutional and retail clients.

Media Contact

ICBC Credit Suisse Asset Management (International) Co. Ltd.

Source: ICBC Credit Suisse Asset Management (International) Company Limited

Written by asiafreshnews

September 15, 2015 at 2:36 pm

Posted in Uncategorized